Protein-protein complexes play key roles in all cellular signal transduction processes. We have developed a fast and accurate computational approach to predict changes in the binding free energy upon alanine mutations in protein-protein interfaces. The approach is based on a knowledge-based scoring function, DrugScore PPI , for which pair potentials were derived from 851 complex structures and adapted against 309 experimental alanine scanning results. Based on this approach, we developed the DrugScore PPI webserver. The input consists of a protein-protein complex structure; the output is a summary table and bar plot of binding free energy differences for wild-type residue-to-Ala mutations. The results of the analysis are mapped on the protein-protein complex structure and visualized using J mol. A single interface can be analyzed within a few minutes. Our approach has been successfully validated by application to an external test set of 22 alanine mutations in the interface of Ras/RalGDS. The DrugScore PPI webserver is primarily intended for identifying hotspot residues in protein-protein interfaces, which provides valuable information for guiding biological experiments and in the development of protein-protein interaction modulators. The DrugScore PPI Webserver, accessible at http://cpclab.uni-duesse ldorf.de/dsppi, is free and open to all users with no login requirement.
INTRODUCTION
Protein-protein interactions have important implications in most cellular signalling networks (1) . Interfering with protein-protein interactions, on the one hand, bears the potential to understand the function of regulatory units in signaling networks and, on the other hand, offers a promising way to develop new therapeutics (2, 3) . The ability to inhibit protein interactions requires knowledge about affinity and specificity in protein interfaces. A powerful tool for analyzing crucial interactions in protein interfaces is provided by experimental alanine scanning mutagenesis (4) . Alanine scanning measures the change in binding free energy (ÁÁG) of a protein-protein complex upon mutation of an amino acid residue to alanine, i.e. the deletion of a sidechain beyond the C b carbon atom. Scanning all amino acids of a protein-protein interface then yields a map of which interactions are critical for protein binding and which ones are not. In fact, protein-protein complex formation depends, in most cases, on only a few interface residues that account for the highest contribution to the binding free energy (5, 6) . These residues are called 'hotspots' (7) . Despite significant advances in molecular biology, alanine scanning still represents a large experimental effort that cannot be applied easily to high-throughput screening of protein-protein interfaces. Hence, there is a strong need for computational approaches to detect hot spots in modeled or experimentally determined protein-protein complexes for which no experimental mutagenesis data is available.
Here, we introduce the DrugScore PPI webserver, a new webservice that offers a user-friendly way of performing alanine scanning in silico. For that purpose, we have developed a fast and accurate computational alanine scanning protocol that, for a given structure of proteinprotein complex, allows an automatic scanning of the protein-protein interface within only a few minutes on a single standard CPU. Our method is grounded on knowledge-based pair potentials derived by following the DrugScore formalism (8) , which has already been applied successfully to score protein-ligand (8) and RNA-ligand interactions (9) . For DrugScore PPI , the statistical potentials were further fine-tuned against experimentally determined alanine scanning results. Application to an independent external test set of alanine mutations demonstrated the predictive power of the method. To date, several computational tools have been developed to perform alanine scanning in silico (10) (11) (12) . The novelty of the DrugScore PPI webservice is rooted, first, in its high accuracy for predicting ÁÁG values, and, second, in its efficiency, allowing to score a single mutant protein-protein complex within seconds.
The webservice is easy to use: as input, a PDB file of the protein-protein complex of interest or a PDB code is required, as is information about the protein chain(s) that should be mutated. The results can either be obtained by email or interactively visualized in the web browser. The results contain a summary table plus a corresponding bar plot detailing computed ÁÁG results, the degree of buriedness of each mutated residue, and a note if a side chain is potentially involved in a salt-bridge. In addition, a PDB file is provided whose B-factor column contains ÁÁG values for visualization with common molecule viewers. The visualization is also possible in the web browser using the Jmol applet (http://jmol. sourceforge.net). To the best of our knowledge, there are no other web services for computational alanine scanning that provide a similar level of integrated structural analysis and visualization capabilities.
MATERIALS AND METHODS

Distance-dependent pair potentials and binding score
For deriving the distance-dependent pair-potentials of the DrugScore PPI scoring function, the same formalism was applied as already described for the DrugScore scoring function for proteinÀligand complexes (8) . The knowledge-based pair potentials for scoring proteinprotein interactions have been derived from 851 crystallographically determined protein-protein complexes using an in-house mySQL database that contains structural information of all PDB entries (E. Schmidt, S. Derksen and H. Gohlke, unpublished results). The dataset consists of 655 homodimers and 196 heterodimers (13) . In all of the cases, the complexes had been resolved to at least 2.5 Å . PDB codes of all complexes used for deriving the potentials are listed in ref. (13) . Potentials were derived for all DrugScore standard atom types that occur in the 20 natural amino acids (8) .
Adaptation of pair potentials using experimental alanine scanning results
DrugScore
PPI was used for computational alaninescanning on a dataset of 18 protein-protein complexes with a total of 309 alanine mutations (14) (Supplementary Table S1 ). These mutations were obtained out of $3000 mutations reported in ASEdb (14) by omitting those mutations (i) for which no PDB structure was available for the protein-protein complex, (ii) which are more than 5 Å away from a respective binding partner because this value is the upper distance limit of the DrugScore PPI potentials and (iii) that stabilize loops or form interactions to other structural elements within the same protein but do not interact with the binding partner. ÁÁG values associated with the latter mutations will very likely report on the stabilization or destabilization of the structure of the one protein rather than on changes in the interactions with the corresponding binding partner. See Supplementary Figure S4 for an example of such a mutation. The average experimental uncertainty for 78 (PDB codes of the corresponding complexes: 1a22, 1a4y, 1bxi, 1dfj, 3hfm) of the 309 mutations amounts to 0.31 kcal mol À1 . Computed and experimental ÁÁG values showed a linear correlation with a coefficient r = 0.58 (Table 1 , Supplementary Figure S1 ) and a standard deviation of 1.06 kcal mol À1 when the original pair potentials were applied. The linear correlation is statistically significant according to a P-value < 0.05.
To improve the predictive power of DrugScore PPI , we decided to adapt the weighting of the distance-dependent pair potentials W(d) in the summation that yields the score for each wild-type amino acid-to-Ala mutation of residue R with atoms r with respect to residues B of the binding partner, which consist of atoms b [Equations (1) and (2)]: 
For this, we identified 24 residue-specific atomtypes T v , e.g. C.3. in Val, C.3. in Leu, C.3. in Phe and so on. Pair potential contributions with low standard deviations across the training set were identified initially, and the respective atomtypes T c were excluded from fitting. These pair potentials were scaled by a factor s. Finally, the degree of buriedness DOB(R) of each residue was used as an additional descriptor scaled by k. The coefficients c T(r) , s and k (Supplementary Table S3) were then determined by correlating experimental and computed ÁÁG values employing partial least squares regression as implemented in MatLab (http://www.mathworks. com). The thus adapted potentials improve the correlation to r train = 0.73 (Supplementary Figure S2) with a root mean square deviation of 0.84 kcal mol À1 (Table 1) . A leave-one-mutation-out cross-validation analysis yielded r LOO = 0.64 and STD = 0.94 kcal mol À1 (Supplementary Figure S3) . A more stringent leave-one-complex-out cross-validation yielded r LCO = 0.63 and STD = 0.96 kcal mol À1 . Both these validations clearly demonstrate the robustness of the model. Finally, a leave-homologous-complexes-out cross-validation yielded r LHO = 0.80 and STD = 0.81 kcal mol À1 . To perform a leave-homologous-complexes-out crossvalidation, we skipped all ribonuclease-like complexes (PDB ID's: 1A4Y and 1DFJ) from the dataset and predicted ÁÁG values for them using adapted potentials derived from the rest of the dataset. The identification of homologous complexes was performed using the ProCKSI-Server (http://www.procksi.net) in this case. For comparison, when original DrugScore PPI potentials were used to predict ÁÁG values for the ribonuclease-like complexes, r = 0.49 and STD = 1.30 kcal mol À1 resulted. In our opinion, this clearly points out an improved predictive power of the adapted potentials compared to the original ones. Finally, we performed an all-against-all similarity search with the FASTA algorithm for all chains of all protein complexes and further analyzed the results by creating a standardized distance matrix. Out of 2048 chain comparisons, only 32 showed significant sequence similarities, thus pointing out the overall diversity of our dataset, which again speaks for the robustness of the model.
Alanine scanning procedure
The flow chart of the DrugScore PPI webservice is depicted in Figure 1 . The DrugScore PPI webserver requires a PDB file of the protein-protein complex as input, which is either downloaded from the RCSB Protein Database (15) or provided by the user. First, all non-peptide molecules and hydrogen atoms are deleted, and all interface residues in a protein-protein interface are identified based on the user-defined chain information. A residue is defined as to be in the interface if it has at least one atom within 5 Å radius of an atom belonging to a binding partner in the protein-protein complex. Next, the degree of buriedness is calculated for each of the interface residues to describe a sidechain's surrounding by considering the number of atoms of nearby residues within a radius of 4 Å . The higher this number, the more buried is a sidechain. Then, pairs of residues that are potentially involved in a salt-bridge, i.e. Asp or Glu within 4 Å distance to Arg or Lys, are detected. Both, the degree of buriedness and the salt-bridge detection are meant to provide a first hint to users for potential hotspots. Finally, each of the interface residues is individually replaced with Ala, and the effect of this mutation on the binding free energy of the complex (ÁÁG) is computed.
Description of the webserver
Input. The DrugScore PPI webservice submission page is shown in Figure 2 . The DrugScore PPI webservice requires a structure of the protein-protein complex provided as PDB file or PDB code, chain identifier(s), and rewriting of a given security code to prevent misuse of the webservice. Optionally, an email address may be provided, in which case the results will be sent to that address. Otherwise, a link to a result page is provided after job submission in order to view the results in the web browser. These results will be stored on the server for ten days.
Providing valid chain identifiers is crucial, for they determine (i) the chain(s) of interest on which interface residues will be mutated to Ala and (ii) which other chains of the protein-protein complex will be considered as 'corresponding chains'. 'Corresponding chains' are those chains that interact with the chain(s) of interest. It is strongly recommended that all chain identifiers of one binding partner be provided, as otherwise intramolecular interactions within this binding partner will also be considered for the ÁÁG computation. If a PDB file with a valid header section is provided, a warning will be issued if this recommendation is not followed.
Some restrictions apply to the PDB input file: (i) Only standard protein residues are considered for ÁÁG computations. (ii) Hydrogen atoms are neither required for nor Figure 1 . Flowchart of the DrugScore PPI webservice illustrating the in silico alanine scanning procedure. . In the case of the leave-one-mutation-out and leave-one-complex-out analyses, STD = [PRESS/(nÀ1)] 1/2 is given, where PRESS equals the sum of squared differences between predicted and experimentally determined binding affinities and n is the number of data points. Summary of results. The first part of the PDF file contains a summary table with four columns ( Figure 3A) . These columns contain, from left to right: (i) the three-letter code of the mutated residue, the residue number and the chain identifier; (ii) the computed relative binding free energy difference ÁÁG for the amino acid-to-Ala mutation, with positive values indicating a potential hot spot residue; (iii) the degree of buriedness for each side chain in the interface; (iv) a note as to whether a residue is potentially involved in a salt-bridge. The second part of the PDF file contains a corresponding bar plot of the ÁÁG results for mutated amino acids ( Figure 3B ). The PDB file contains the input protein-protein complex structure with computed ÁÁG values in the B-factor column. This file can be used to color residues in the interface according to their sidechains' contributions to the binding free energy, e.g. with PyMol (http://pymol.sour ceforge.net) or VMD (http://www.ks.uiuc.edu/Research/ vmd/). Finally, warnings are provided about input structure characteristics that might have influenced the results ( Figure 4A ). As such, a list of missing residues and/or atoms as declared in the PDB header is presented because missing interface atoms or residues will certainly lead to false ÁÁG computations. Furthermore, if corresponding information is available in the PDB header, a warning is issued if not all chain identifiers of one binding partner have been provided, as in this case intramolecular interactions within this binding partner were also considered for the ÁÁG computation.
Annotated structure. In the web browser, alanine scanning results by DrugScore PPI are visualized directly by mapping ÁÁG values onto the protein-protein complex structure using the Jmol applet (http://jmol.sourceforge.net) ( Figure 4C ). For this, residues in the interface are represented by a color code according to their sidechains' contribution to the binding free energy, with reddish colors indicating hot spot residues, as detailed by the provided color scale. The chain(s) of the protein for which residue contributions were calculated is (are) colored in white; the corresponding chain(s) of the binding partner(s) is (are) colored in magenta.
Limitations. Based on the implementation of our approach, several assumptions are made that can affect the applicability of the method, which should be considered when interpreting the results. (i) As ÁÁG values are calculated from the protein-protein complex structure only, both binding partners are assumed to have the same unbound and bound conformations, respectively. Consequently, contributions to ÁÁG due to changes in intramolecular interactions upon complex formation are not considered, which poses a limitation in those cases where conformational changes upon binding and/or unfolding-to-folding transitions of the binding partners are expected. (ii) Non-peptide ligands, cofactors, metal ions and water molecules are not taken into account. Energetic contributions to ÁÁG for sidechains contacting these molecular species are thus missing. (iii) Due to the nature of knowledge-based scoring functions, all terms in DrugScore PPI are pairwise additive. For that reason, cooperative effects between mutations, as have been observed in double-mutant cycles (16), are not taken into account. This is also a reason why indirect effects exerted by residues not making direct interactions in the interface are generally not captured, as described above. Likewise, only interactions between atoms at a distance < 5 Å are scored, thus neglecting long-range contributions due to, e.g. electrostatic interactions. Finally, the knowledge-based potentials represent 'effective pair energies' (8, 17) and, thus, are expected to implicitly cover van der Waals, electrostatic and (de-)solvation contributions. However, they neglect changes in the dynamics of the binding partners upon complex formation, which can lead to significant entropic contributions to ÁÁG (17) . (iv) The symmetry of protein-protein complexes is not taken into account. That is, in symmetric interfaces, only one residue at a time is considered during alanine scanning, whereas symmetry-related corresponding residues in the other binding partner(s) are modeled as wild-type. However, due to the additive nature of the pair potentials, single contributions of symmetry-related residues may be added.
Implementation. The DrugScore PPI webserver has been implemented in Python, as have been the subroutines to calculate the degree of buriedness and to detect possible saltbridges. The DrugScore PPI scoring routine has been implemented in C+ +. Given the low computational demand of our approach, up to 10 submitted jobs can be run in parallel at present. Table ( A) and bar plot (B) of binding free energy differences for wildtype residue-to-Ala mutations. Positive binding free energy differences indicate a potential hot spot residue. In addition to the binding free energy differences, in (A) the degree of buriedness of a sidechain is given, as is a note as to whether the sidechain is involved in a salt bridge.
Application to the protein-protein complex Ras/RalGDS
To evaluate the predictive power of the DrugScore PPI webservice using the adapted DrugScore PPI potentials, ÁÁG values were computed for interface residues in the protein-protein complex Ras/RalGDS (PDB code: 1lfd) and compared to experimental values for 22 alanine mutants (Supplementary Table S2 ) taken from ref. (18) . We note that the Ras/RalGDS complex was not part of the training set to adapt the pair potentials and, thus, provides an independent external test case. A predictive correlation coefficient r pred = 0.66 was found (Table 2) , which is close to r LOO = 0.64 from the leave-onemutation-out cross-validation, again demonstrating the robustness of the model. The predictive power of the adapted DrugScore PPI scoring function was then compared to four other computational methods that are able to predict changes in the binding free energy upon alanine mutations in protein interfaces: FoldX (12), MM/ GBSA (17), the CC/PBSA method (19) and Robetta (20) ( Figure 5 ). As demonstrated by the statistical parameters given in Table 2 , the adapted DrugScore PPI potentials significantly outperform the CC/PBSA, FoldX and Robetta methods with respect to predictive power and perform as good as the MM/GBSA method, which had been applied to a subset of 16 mutations. In addition, DrugScore PPI is the most efficient method, as it only requires about three seconds per residue for this system on a standard CPU.
We note that the external validation dataset consisting of 22 mutations is rather small. However, the lack of a reasonably large and independent test set to validate and compare different methods is a common problem in this field. At least for the adapted DrugScore PPI potentials, due to the overall diversity of our training dataset, each leave-one-complex-out cross-validation step comes close to testing against an independent test set. Thus, we consider this cross-validation (Table 1) to be strongly indicative of the predictive power of our method.
CONCLUSIONS
The development of the DrugScore PPI webserver was motivated by a growing demand for comprehensive tools assisting research in the field of protein-protein recognition. The DrugScore PPI webserver allows fast and accurate in silico alanine scanning based on adapted knowledge-based distance-dependent pair potentials. The approach has been successfully validated on an independent external test set, and the results on this dataset compare favorably with other established methods. The DrugScore PPI webserver is primarily intended for identifying hotspot residues in protein-protein interfaces. Knowledge of potential hotspot residues is valuable for guiding biological experiments and in the development of protein-protein interaction modulators (2) . A userfriendly interface, minimal demands on input information, and a detailed output as well as an embedded visualization capability make this web server potentially useful for users without a prior knowledge of structural bioinformatics analyses. Overall, we expect the DrugScore PPI webserver to be a valuable tool for predicting hotspots in proteinprotein interfaces. 
